Pancreatic Biliary Cancer Cohort study

Pancreatic Biliary Cancer Cohort study - PBCC

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056796

Enrollment

3000

Registered

2025-02-01

Start date

2023-11-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer, Biriary tract cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients treated for biliopancreatic cancer at Yamanashi Prefectural Central Hospital and the collaborating institutions between the date of approval by the head of the research institution and December 31, 2027. (2) Target disease: pancreatic cancer, biliary tract cancer (3) Age: 18 years and older (4) Gender: Any gender (5) Patients who have been explained about this study and have obtained a consent form for this study.

Exclusion criteria

Exclusion criteria: Patients who fall under any one of the following will be excluded from the study. (1) Patients who have refused to participate in this study. (2) Patients who are deemed inappropriate as research subjects by the investigators, etc.

Design outcomes

Primary

Measure	Time frame
Overall survival, progression-free survival, and disease control rate per treatment	—

Secondary

Measure	Time frame
Examination of prognosis-related factors	—

Countries

Japan

Contacts

Public ContactSumio Hirose

Yamanashi Prefectural Central Hospital Gastroenterology Department

chubyo@ych.pref.yamanashi.jp0552537111

Outcome results